SPY317.59+3.21 1.02%
DIA260.82+3.58 1.39%
IXIC10,617.44+69.69 0.66%

Piper Sandler Initiates Coverage On Pliant Therapeutics with Overweight Rating, Announces Price Target of $50

Piper Sandler analyst Tyler Van Buren initiates coverage on Pliant Therapeutics (NASDAQ:PLRX) with a Overweight rating and announces Price Target of $50.

Benzinga · -
Piper Sandler analyst Tyler Van Buren initiates coverage on Pliant Therapeutics (NASDAQ: PLRX) with a Overweight rating and announces Price Target of $50.